ProQR Therapeutics NV (ProQR Therapeutics NV) Operating Cash Flow per Share : $0.28 (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Operating Cash Flow per Share?

ProQR Therapeutics NV's operating cash flow per share for the three months ended in Dec. 2023 was $-0.07. ProQR Therapeutics NV's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.28.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for ProQR Therapeutics NV's Operating Cash Flow per Share or its related term are showing as below:

During the past 12 years, ProQR Therapeutics NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was 21.60% per year. The lowest was -120.60% per year. And the median was 5.60% per year.

PRQR's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.7
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

ProQR Therapeutics NV Operating Cash Flow per Share Historical Data

The historical data trend for ProQR Therapeutics NV's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Operating Cash Flow per Share Chart

ProQR Therapeutics NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.19

-1.14

-0.46

-1.01

0.29

ProQR Therapeutics NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.26	0.59	-0.14	-0.10	-0.07

Competitive Comparison of ProQR Therapeutics NV's Operating Cash Flow per Share

For the Biotechnology subindustry, ProQR Therapeutics NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProQR Therapeutics NV's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProQR Therapeutics NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ProQR Therapeutics NV's Price-to-Operating-Cash-Flow falls into.

ProQR Therapeutics NV Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

ProQR Therapeutics NV's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	23.498	/	81.011
	=	0.29

ProQR Therapeutics NV's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-5.804	/	81.217
	=	-0.07

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.28

ProQR Therapeutics NV Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ProQR Therapeutics NV (ProQR Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

0PQ:Germany

Address

Zernikedreef 9, Leiden, ZH, NLD, 2333 CK

Website

https://www.proqr.com

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.